Explore more updates
Topics
Period
recent search
Showing: 1 – 05 of 14 Media Updates
–
09 January 2026
09 January 2026
–
22 December 2025
22 December 2025
Ipsen, Université de Montréal and IRICoR expand long-term partnership to accelerate early-stage oncology innovations
PARIS, FRANCE AND MONTREAL, CANADA 22 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), Université de Montréal and IRICoR, of the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal, announced today a new research collaboration…
–
05 December 2025
05 December 2025
Ipsen provides update on legacy of Henri Beaufour
PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be transferred to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour, Ipsen’s Board Member and a representative…
–
14 October 2025
14 October 2025
Ipsen announces the conclusion of an agreement between its main shareholders representing 52.06% of the capital and 66.15% of the voting rights
PARIS, FRANCE, 14 OCTOBER 2025 – Ipsen (Euronext: IPN: ADR: IPSEY) announced today that its Board of Directors has been informed of the conclusion of a new agreement1 between Highrock (controlled by Anne Beaufour), Beech Tree (controlled by Henri Beaufour)…
–
13 October 2025
13 October 2025
ESMO 2025: new data reinforces breadth and depth of Ipsen’s growing oncology pipeline and portfolio
PARIS, FRANCE, 13 October 2025 – Ipsen announced today data to be presented at the upcoming European Society of Medical Oncology (ESMO) Symposium on 17-21 October 2025 for rare cancers and complex tumors, offering opportunities to change the course of…
